Stonnington Group’s ResMed RMD Stock Holding History

Stonnington Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$5.68M	Sell	25,086 -660	-3%	-$143K	1.48%	11
2022 Q4	$5.48M	Sell	25,746 -855	-3%	-$188K	1.51%	12
2022 Q3	$5.73M	Buy	26,601 +855	+3%	+$195K	1.61%	11
2022 Q2	$5.67M	Buy	25,746 +60	+0.2%	+$12.8K	1.51%	13
2022 Q1	$6.22M	Sell	25,686 -240	-0.9%	-$58.1K	1.49%	14
2021 Q4	$6.18M	Sell	25,926 -80	-0.3%	-$20.8K	1.33%	15
2021 Q3	$6.6M	Sell	26,006 -203	-0.8%	-$55.5K	1.48%	14
2021 Q2	$6.57M	Sell	26,209 -155	-0.6%	-$32.6K	1.46%	11
2021 Q1	$5.07M	Buy	+26,364	New	+$5.29M	1.23%	14

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stonnington Group's RMD Position: Q1 2023 in Review

Stonnington Group reduced its ResMed (RMD) stake by 2.6% in Q1 2023, selling an estimated $143K and leaving 25,086 shares worth $5.68M. The position accounts for 1.48% of the portfolio, ranked #11.

Stonnington Group first reported a position in RMD in Q1 2021 and has held it in 9 quarters since. The position peaked at $6.6M in Q3 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

Stonnington Group held 25,086 shares of ResMed worth $5.68M as of Q1 2023.
Stonnington Group sold 660 ResMed shares in Q1 2023, an estimated $143K.
ResMed made up 1.48% of Stonnington Group's portfolio in Q1 2023, its #11 holding.
Stonnington Group first reported a position in ResMed in Q1 2021 and has held it in 9 quarters since.
Stonnington Group's ResMed position peaked at $6.6M in Q3 2021.
676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.